Treatment of Gorham’s disease with zoledronic acid
Authors:
- M D MignognaMMM D Mignogna
- S. FedeleSFS. Fedele
- L. Lo RussoLRL. Lo Russo
- R. CiccarelliRCR. Ciccarelli
- 1 August 2005
- journal article
- case report
- Published by Elsevier in Oral Oncology
- Vol. 41 (7) , 747-750
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Massive osteolysis (Gorham disease) of the maxillofacial skeleton: report of 2 casesJournal of Oral and Maxillofacial Surgery, 2004
- The anti-tumor potential of zoledronic acidThe Breast, 2003
- Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham–Stout diseaseThe Journal of Pathology, 2001
- Angiomatosis of Bone and Soft Tissue: A Spectrum of Disease from Diffuse Lymphangiomatosis to Vanishing Bone Disease in Young PatientsClinical Radiology, 2001
- Gorham’s disease: A case (including dental presentation) of vanishing bone diseaseOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2000
- α-2b interferon and oral clodronate for Gorham's diseaseThe Lancet, 1997
- Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout diseaseThe Journal of Clinical Endocrinology & Metabolism, 1996
- Chylothorax in Gorham's SyndromeChest, 1994
- Seven‐year follow‐up of vanishing bone disease in a 14‐year‐old girlHead & Neck, 1993
- Gorham's syndrome: A case report and review of the literatureThe American Journal of Medicine, 1987